KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned (2016 - 2023)

Historic Times Interest Earned for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Q2 2023 value amounting to -$19.33.

  • Supernus Pharmaceuticals' Times Interest Earned fell 40830.9% to -$19.33 in Q2 2023 from the same period last year, while for Mar 2024 it was -$14.94, marking a year-over-year decrease of 30091.21%. This contributed to the annual value of -$2.18 for FY2023, which is 13344.29% down from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Times Interest Earned stood at -$19.33 for Q2 2023, which was down 40830.9% from $3.44 recorded in Q1 2023.
  • In the past 5 years, Supernus Pharmaceuticals' Times Interest Earned registered a high of $21.54 during Q4 2022, and its lowest value of -$19.33 during Q2 2023.
  • Moreover, its 5-year median value for Times Interest Earned was $5.87 (2021), whereas its average is $4.58.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Times Interest Earned surged by 199602.38% in 2022 and then plummeted by 40830.9% in 2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Times Interest Earned (Quarter) stood at $7.07 in 2019, then decreased by 0.17% to $7.05 in 2020, then plummeted by 85.43% to $1.03 in 2021, then soared by 1996.02% to $21.54 in 2022, then tumbled by 189.73% to -$19.33 in 2023.
  • Its last three reported values are -$19.33 in Q2 2023, $3.44 for Q1 2023, and $21.54 during Q4 2022.